EHRA/HRS Expert Consensus on Catheter Ablation of Ventricular Arrhythmias
Developed in a partnership with the European Heart Rhythm Association (EHRA), a Registered Branch of the European Society of Cardiology (ESC), and the Heart Rhythm Society (HRS); in collaboration with the American College of Cardiology (ACC) and the American Heart Association (AHA)
The purpose of this Consensus Statement is to provide a state-of-the-art review of the field of catheter ablation of ventricular tachycardia (VT), and to report the findings of a Task Force, convened by the European Heart Rhythm Association (EHRA) and the Heart Rhythm Society (HRS) that was charged with defining the indications, techniques, and outcomes of this procedure.
This statement summarizes the opinion of the Task Force members based on their own experience in treating patients, as well as a review of the literature. It is directed to all healthcare professionals who treat patients who are considered for catheter ablation of VT. This statement is not intended to recommend or promote catheter ablation of VT. Rather, the ultimate judgement regarding care of a particular patient must be made by the healthcare provider and the patient with consideration of the individual patient characteristics that impact on risks and benefits of the therapy.
Expert Consensus on Catheter Ablation of Ventricular Arrhythmias offers guidance on a range of issues including:
- Indications for catheter ablation of ventricular tachycardia
- Technical aspects such as mapping systems, robotic navigation, imaging, energy sources for ablation, anticoagulation and arrhythmic drug management
- Mechanisms of specific types of VTs
- Ablation outcomes and considerations in specific diseases
- Ablation approaches and outcomes for idiopathic VTs that are not due to structural heart disease
- Training, institutional requirements and competencies for centers and physicians performing ablation
- Clinical trial considerations and needs for future research
